Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Legislation (77)
- Safety monitoring and information (41)
- Advertising (25)
- Manufacturing (19)
- Labelling and packaging (17)
- COVID-19 (15)
- Vaping hub (13)
- Compliance and enforcement (7)
- Scheduling (national classification system) (6)
- Import and export (2)
- Sunscreens (2)
- Clinical trials (1)
- Committees and advisory bodies (1)
- Medicinal cannabis hub (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
334 result(s) found, displaying 151 to 175
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
Regulatory decision noticesThe TGA has issued a direction notice to 13 Vape Pty Ltd and an executive officer to cease promoting the use and supply of nicotine vaping products to Australian consumers.
-
Regulatory decision noticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2022.
-
Regulatory decision noticesThis labelling exemption is granted under section 1.1(3) of Part 2 of the current Poisons Standard.
-
Regulatory decision noticesThe TGA has issued a direction notice to Phenix Health Pty Ltd to cease alleged unlawful advertising of nicotine vaping products.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Regulatory decision noticesDirection Notice issued to cease advertisement of prescription and illegal products
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Regulatory decision noticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1992.
-
Regulatory decision noticesThis Order may be cited as Therapeutic Goods (Groups) Order No. 1 of 1992.
-
Regulatory decision noticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1991.
-
Safety updatesWhen new safety information for medicines is identified, the Therapeutic Goods Administration (TGA) works with the sponsors to update Product Information (PI) to ensure that health professionals and consumers have access to this information.
-
Regulatory decision noticesThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 12 to 15 years old.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Regulatory decision noticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2022.
-
Regulatory decision noticesSix monthly report – supply of unapproved therapeutic goods by a sponsor.
-
Regulatory decision noticesPrevention notice under section 42DKB of the Therapeutic Goods Act 1989.
-
Regulatory decision noticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
Safety updatesMedicines safety update - important information for health professionals
-
Safety updatesMedicines Safety Update - Information for health professionals